Ever since RFK Jr has taken over HHS, a lot has changed. Whether it is about US pulling out of global health funding or ...

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...

Key Points Dynavax Technologies (NASDAQ:DVAX) exceeded analyst expectations in Q2 2025, reporting GAAP revenue of $95.4 million and GAAP diluted EPS of $0.14. HEPLISAV-B, Dynavax's two-dose adult ...

In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...

The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous ...

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

The FDA had halted use in older adults while it investigated reports of side effects. The vaccine’s label now carries new ...

Over the past two centuries, vaccines have been critical for preventing infectious diseases. The World Health Organization ...

As part of a postmarketing requirement, Valneva will be initiating a study to assess the risk of severe chikungunya-like adverse reactions following administration of Ixchiq.

Over the past two centuries, vaccines have been critical for preventing infectious diseases. The World Health Organization ...

While anti-vaxxers are thrilled, experts warn that defunding mRNA development takes away our already-proven best weapon ...